“There is currently no real-time objective measure,” says Viviane Nasr, MD, an anesthesiologist with Boston Children’s Hospital’s Division of Cardiac Anesthesia. “Instead, respiratory assessment relies on oximetry data, a late indicator of respiratory decline, and on subjective clinical assessment.”
A new device, recently cleared by the FDAfor children 1 year and older in medical settings, provides an easy, noninvasive way to tell how much air the lungs are receiving in real time. It can signal problems as much as 15-30 minutes before standard pulse oximetry picks up low blood oxygenation, according to one study.
A wearable watchdog
Called ExSpiron, the device is essentially a wearable attached to a monitor. A pair of disposable electrodes stick onto the child’s chest and, similar to body fat measurements, send a small current through the chest. The device detects the amount of impedance or resistance the current encounters and thereby calculate the volume of air in the lungs with each breath.
ExSpiron was originally developed for adults. To encourage its adaptation for the much smaller pediatric market, the Innovation and Digital Health Accelerator at Boston Children’s Hospital provided support via the FDA-funded Boston Pediatric Device Consortium (BPDC).
A study led by Nasr, published in December in Anesthesia and Analgesia, tested the device in 72 children who received general anesthesia with endotracheal intubation. ExSpiron measurements agreed well with “gold standard” measurements from an in-line monitoring spirometer.
Read the full blog post: “Stick-on respiratory monitor allows early detection of breathing problems” on Vector Blog
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.
